Rheumatoid Arthritis
Showing NaN - NaN of 110
Rheumatoid Arthritis Trial in United States (Infliximab, Methotrexate, Methylprednisolone)
Rheumatoid Arthritis Trial in Worldwide (SKI-O-703, Placebo)
Unknown status
- Rheumatoid Arthritis
- SKI-O-703
- Placebo
-
Beverly Hills, California
- +39 more
Oct 8, 2020
Rheumatoid Arthritis Trial in Australia, United States (Allogeneic Mesenchymal Precursor Cells, Normal Saline)
Completed
- Rheumatoid Arthritis
- Allogeneic Mesenchymal Precursor Cells
- Normal Saline
-
Anniston, Alabama
- +22 more
Jun 25, 2020
Rheumatoid Arthritis Trial in Worldwide (PF-06650833, Placebo, Tofacitinib)
Rheumatoid Arthritis Trial in Worldwide (Anti-TNF-alpha, Methotrexate, Placebo)
NSAID-induced Gastroduodenal Injury, Ulcers, Rheumatoid Arthritis Trial in United States (Cobiprostone, Placebo, Non-steroidal
Completed
- NSAID-induced Gastroduodenal Injury
- +3 more
- Cobiprostone
- +2 more
-
Phoenix, Arizona
- +18 more
Dec 10, 2019
Rheumatoid Arthritis Trial in Worldwide (PF-05280586, MabThera, Rituxan)
Completed
- Rheumatoid Arthritis
- PF-05280586
- +2 more
-
Birmingham, Alabama
- +83 more
Oct 30, 2019
Rheumatoid Arthritis Trial in Worldwide (Baricitinib, Methotrexate, Baricitinib Placebo)
Rheumatoid Arthritis Trial in Worldwide (Adalimumab, Baricitinib, Methotrexate)
Osteoarthritis, Avascular Necrosis, Rheumatoid Arthritis Trial in United States (Cormet Hip Resurfacing)
Completed
- Osteoarthritis
- +2 more
- Cormet Hip Resurfacing
-
Washington, District of Columbia
- +5 more
Jun 12, 2019
Rheumatoid Arthritis Trial in Worldwide (Etanercept, CHS-0214)
Completed
- Rheumatoid Arthritis
-
Phoenix, Arizona
- +140 more
Jun 7, 2019
Rheumatoid Arthritis Trial in Worldwide (Rituximab-Pfizer (PF-05280586) x 3 courses, Rituximab-EU+ Rituximab-Pfizer x 2 Courses,
Completed
- Rheumatoid Arthritis
- Rituximab-Pfizer (PF-05280586) x 3 courses
- +2 more
-
Birmingham, Alabama
- +70 more
Jan 8, 2019
Rheumatoid Arthritis Trial in Worldwide (PF-06410293, Adalimumab)
Completed
- Rheumatoid Arthritis
- PF-06410293
- Adalimumab
-
Gilbert, Arizona
- +182 more
Jan 18, 2019
Degenerative Joint Disease, Congenital Deformity, Arthritis Trial in Canada, United States (Augment® Injectable Bone Graft,
Completed
- Degenerative Joint Disease
- +4 more
- Augment® Injectable Bone Graft
- Autologous bone graft
-
Tucson, Arizona
- +24 more
Dec 4, 2018
Inflammation, Rheumatoid Arthritis Trial in Worldwide (NNC0109-0012, )
Terminated
- Inflammation
- Rheumatoid Arthritis
- NNC0109-0012
- placebo
-
Huntington Beach, California
- +139 more
Sep 3, 2018
Inflammation, Rheumatoid Arthritis Trial in Worldwide (NNC0109-0012, )
Terminated
- Inflammation
- Rheumatoid Arthritis
- NNC0109-0012
- placebo
-
Huntsville, Alabama
- +163 more
Sep 3, 2018
Rheumatoid Arthritis Trial in Czechia, United States (INCB028050, Placebo)
Rheumatoid Arthritis Trial in Worldwide (Certolizumab pegol (CZP), Placebo)
Completed
- Rheumatoid Arthritis
- Certolizumab pegol (CZP)
- Placebo
-
Birmingham, Alabama
- +180 more
Jul 4, 2018
Rheumatoid Arthritis Trial in United States (Certolizumab Pegol (CZP))
Completed
- Rheumatoid Arthritis
- Certolizumab Pegol (CZP)
-
Birmingham, Alabama
- +109 more
Jul 4, 2018
Rheumatoid Arthritis Trial in Worldwide (Certolizumab Pegol + Methotrexate (MTX), Placebo + Methotrexate (MTX))
Completed
- Rheumatoid Arthritis
- Certolizumab Pegol + Methotrexate (MTX)
- Placebo + Methotrexate (MTX)
-
Birmingham, Alabama
- +177 more
Jul 4, 2018
Rheumatoid Arthritis Trial in Worldwide (Certolizumab Pegol, Placebo, Methotrexate)
Completed
- Rheumatoid Arthritis
- Certolizumab Pegol
- +2 more
-
Birmingham, Alabama
- +177 more
Jul 4, 2018